Which Factors Help to Determine the Long-Term Response to First-Line Tyrosine Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma: A Turkish Multi-Centre Study. Biomol Biomed 2024. https://doi.org/10.17305/bb.2024.10512.